|
Bieżący numer
Archiwum
Filmy
Artykuły w druku
O czasopiśmie
Suplementy
Rada naukowa
Recenzenci
Bazy indeksacyjne
Prenumerata
Kontakt
Zasady publikacji prac
Opłaty publikacyjne
Standardy etyczne i procedury
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
|
Opis przypadku
Diagnosis and management of uveitis-glaucoma-hyphema syndrome
Maria Guszkowska
1
,
Monika Popowska
1
,
Monika Lazicka-Galecka
1, 2
,
Tomasz Galecki
2
,
Anna Kaminska
1, 2, 3
,
Jacek Pawel Szaflik
1, 2, 3
KLINIKA OCZNA 2025, 127
Data publikacji online: 2025/09/05
Plik artykułu:
- KO-00558_EN.pdf
[0.24 MB]
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
1. Ellingson FT. The uveitis-glaucoma-hyphema syndrome associated with the mark viii anterior chamber lens implant. Am Intra-Ocul Implant Soc J 1978; 4: 50-53. 2.
Capitena Young CE, St Peter DM, et al. Hydrus microstent malposition with uveitis-glaucoma-hyphema syndrome. Am J Ophthalmol Case Rep 2022; 25: 101405. 3.
Apple DJ, Mamalis N, Loftfield K, et al. Complications of intraocular lenses: a historical and histopathological review. Surv Ophthalmol 1984; 29: 1-54. 4.
Accorinti M, Saturno MC, Paroli MP, et al. Uveitis-glaucoma-hyphema syndrome: clinical features and differential diagnosis. Ocul Immunol Inflamm 2022; 30: 1408-1413. 5.
Sousa DC, Leal I, Faria MY, Pinto LA. A rare manifestation of uveitis-glaucoma-hyphema syndrome. J Curr Glaucoma Pract 2016; 10: 76-78. 6.
Zhang L, Hood CT, Vrabec JP, et al. Mechanisms for in-the-bag uveitis-glaucoma-hyphema syndrome. J Cataract Refract Surg 2014; 40: 490-492. 7.
Foroozan R, Tabas JG, Moster ML. Recurrent microhyphema despite intracapsular fixation of a posterior chamber intraocular lens. J Cataract Refract Surg 2003; 29: 1632-1635. 8.
Rhéaume MA, Duperré J, Harasymowycz P, Thompson P. Pigment dispersion and recurrent hyphema associated with in-the-bag lens implantation. J Cataract Refract Surg 2009; 35: 1464-1467. 9.
Hunter A, Bukspan C, Greenberg PB, et al. Uveitis glaucoma hyphema plus syndrome: a case report. CRO J 2025; doi: 10.57204/001c.128216. 10.
Piette S, Canlas O, Tran H, et al. Ultrasound biomicroscopy in uveitis-glaucoma-hyphema syndrome. Am J Ophthalmol 2002; 133: 839-841. 11.
Ramakrishnan MS, Wald KJ. Current concepts of the uveitis-glaucoma-hyphema (UGH) syndrome. Curr Eye Res 2023; 48: 529-535. 12.
Zhou Y, Bicket AK, Marwah S, et al. Incidence of acute cystoid macular edema after starting a prostaglandin analog. Ophthalmol Glaucoma 2025; 8: 4-11. 13.
Hu J, Vu JT, Hong B, et al. Uveitis and cystoid macular oedema secondary to topical prostaglandin analogue use. Br J Ophthalmol 2020; 104: 1040-1044. 14.
Du Y, Zhu X, Yang J, et al. Uveitis-glaucoma-hyphema syndrome with sclera-fixed posterior-chamber IOL. BMC Ophthalmol 2020; 20: 22. 15.
Kandarakis SA, Petrou P, Katsimpris A, et al. UGH syndrome resolution after IOL explantation. Ocul Immunol Inflamm 2023; 32: 320-325. 16.
Ishida K, Yamamoto T, Sugiyama K, Kitazawa Y. Cystoid macular edema after posterior chamber intraocular lens implantation. J Cataract Refract Surg 2004; 30: 812-817. 17.
Liesegang TJ. Intraocular lens implantation and uveitis. Surv Ophthalmol 1984; 29: 1-54. 18.
Saenz-de-Viteri M, Garcia-Gomez PJ, Sádaba-Echarri I, et al. Cystoid macular edema after cataract surgery. Arch Soc Esp Oftalmol 2015; 90: 409-415. 19.
Arogundade FA, Sanusi AA, Onadeko MO. Cycloplegic effect of tropicamide in uveitis patients. Afr Health Sci 2017; 17: 908-912. 20.
Smith JR, Rosenbaum JT. Retinal complications from prostaglandin analogues in patients with uveitis. Ophthalmology 2020; 127: 1040-1044. 21.
Ishida K, Yamamoto T, Sugiyama K. Persistent cystoid macular edema after posterior chamber intraocular lens implantation. Case Rep Ophthalmol Med 2017; 2017: 5710046.
|
ENGLISH
